SC

START Center for Cancer Care at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

START Center for Cancer Care takes part in 3 sessions at ESMO 2026 in Madrid. Its program centres on early drug development, including a bispecific antibody against TGFβR2 and PD-1 given with standard therapy in microsatellite-stable colorectal cancer. It also addresses shared decision-making and closing communication gaps with patients to improve adherence and outcomes.

OrganizationESMO 2026 Attendance
SC
START Center for Cancer Care
San Antonio, TX
Cancer centre & hospital
Network of early-phase oncology clinical trial sites, headquartered in San Antonio, Texas, with sites in the US and Europe.
Chair
Sun Oct 25
08:30–10:00
Rapid oral: Developmental therapeutic
with University of Oxford, Gustave Roussy
Abstract
Sun Oct 25
09:07–09:17
Invited Discussant 1004RO and 1005RO
Rapid oral: Developmental therapeutic
Satellite
Sun Oct 25
13:40–14:00
Turning Decisions into Action: Practical Tools for Implementing Shared Decision-Making
Lilly - Translating treatment decisions into patient Palacio Municipal outcomes: practical approaches to communication, adherence and care delivery
Nursing & supportive care
Satellite
Sun Oct 25
14:00–14:20
What Matters Most to Patients? Bridging Communication Gaps to Improve Outcomes
Lilly - Translating treatment decisions into patient Palacio Municipal outcomes: practical approaches to communication, adherence and care delivery · with Clínica Universidad de Navarra, The Global Gene, University of South-Eastern Norway
Nursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from START Center for Cancer Care

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction